CRE26-066: Clindamycin-Induced Immune-Mediated Thrombocytopenia: A Rare and Potentially Life-Threatening Adverse Reaction (First Reported U.S. Case to Our Knowledge).
Publication/Presentation Date
3-31-2026
Volume
24
Issue
3.5
ISSN
1540-1413
Published In/Presented At
Butt, D., Shrestha, B. M., Balla, M., Iqbal, A., Ud Din, S., & Hamouda, D. (2026). CRE26-066: Clindamycin-Induced Immune-Mediated Thrombocytopenia: A Rare and Potentially Life-Threatening Adverse Reaction (First Reported U.S. Case to Our Knowledge). Journal of the National Comprehensive Cancer Network : JNCCN, 24(3.5), CRE26-066. https://doi.org/10.6004/jnccn.2025.7200
Disciplines
Medicine and Health Sciences
PubMedID
41991035
Department(s)
Department of Medicine
Document Type
Article
COinS